In Toronto, an international study is underway for an experimental drug for people with Autism Spectrum Disorder (ASD), and the community is divided on the use of the drug manufactured by the sponsor Hoffmann-La Roche. Called Balovaptan, the drug could potentially...
Phlexglobal, a UK-based outsourced clinical trial master file service provider and software developer, has acquired Cunesoft, a niche Munich-based regulatory data and document management upstart from its shareholders, including Bayern Kapital, High-Tech Gründerfonds,...
The Institute of Vaccines and Medical Biologicals (IVAC) in Vietnam recently conducted a vaccine study concluding that a potential counter to pandemic threats from A(H5N1) influenza may also involve priming the target population with A(H5N1) vaccine, and after that...
A research team from Henry Ford Hospital recently suggested in a medical research paper that treating hidradenitis suppurativa more effectively could involve not one medication, but rather a multimodal approach including not only topical and systemic therapies, but...
North Carolina biotech entrepreneur Adnan Mjalli at Oasis Investment Group will develop a $425 million research park on 80 acres of newly annexed land in High Point. This development represents a new model of clinical research, where a confluence of infrastructure,...
About one-third of childhood cancer deaths in the UK result from brain cancers. The Brain Tumour Charity recently reported that the University of Birmingham, the clinical investigative site, developed a new personalized approach that can help clinicians give more...
